首页|Inhibition of Differentiation by Transforming Growth Factor β1 in Rhabdomyosarcoma Cells
Inhibition of Differentiation by Transforming Growth Factor β1 in Rhabdomyosarcoma Cells
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
维普
OBJECTIVE To study the effect of transforming growth factor β1 (TGF-β1) on differentiation of rhabdomyosarcoma (RMS) cells METHODS RD (human embryonal RMS cell line) cells, cultured in differentiation medium containing 9-cis retinoic acid (9CRA), were treated with TGF-β1. Proliferation of the cells was examined by the MTT assay. The differentiation specific proteins (sarcomeric actin and MyHC) and myogenic transcription factors (MyoD1 and myogenin) in the RD cells were assessed by immunofluorescence staining.RESULTS Compared to control cells, treatment with lower concentrations of TGF-β1 (0.1 and 0.2 ng/ml) induced an increase in OD values after 4 d (P＜0.01), whereas higher concentrations of TGF-β1 (2 and 5 ng/ml) led to a reduction of cell viability (P＜0.01). After exposure to 9CRA, the viability of the cells decreased significantly (P＜0.01), while sarcomeric actin, MyHC and myogenin were induced. These changes were antagonized by TGF-β1 (0.1 ng/ml). No changes were observed in expression of MyoD1.CONCLUSION The RMS cells, derived from myogenic progenitors are committed to a myogenic fate, but are arrested in the differentiation course by the addition of TGF-β1 which represses some of the myogenic transcription factors.
Molecular Pathology Laboratory,Medical School of Soochow University,Suzhou 215123,China
Department of Surgery,the Second Affiliated Hospital of Soochow University,Suzhou 215123,China
Pharmacology Laboratory,Medical School of Soochow University,Suzhou 215123,China
Jiangshu Provincial Higher Institution Natural Science FoundationSoochow Universtiy Medicine Development FoundationJiangshu Provincial Post-Doctoral Foundation
NETL
NSTL
万方数据
维普
